Tag: MiMedx
New Study Demonstrates Potential for MIMEDX Purion® Processed Dehydrated Human Amnion/Chorion...
Proposed Mechanism Suggests Potential Path to Improve Outcomes in Clinical Applications where the Regulation of Excessive Fibrosis Can Promote a Normal Healing Response...
MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting...
Urges Shareholders to Vote the WHITE Proxy Card “FOR ALL” Four of MIMEDX’s Director Nominees – Dr. Kathleen Behrens, Mr. Todd Newton, Mr....
MiMedx Announces First Quarter 2021 Financial and Operating Results
First Quarter Net Sales of $60.0 Million Advancing Innovative Late-Stage Musculoskeletal Pipeline with Data Readouts Expected in Q3 2021 Company to...
MiMedx Announces Appointment of Phyllis Gardner, M.D. to Board of Directors
Noted biopharmaceutical thought leader adds academic, research and industry expertise MARIETTA, Ga., March 08, 2021 (GLOBE NEWSWIRE) -- MiMedx Group,...